In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1858 News Items found
Images from three different mice showing the effects of antibiotics and microbiome replacement
In the Lab
Bacteria versus Bacteria: Two Studies Uncover Species of Microbes That Protect against Infections in People with Cancer

Research recently published by MSK scientists suggests that the best way to fight dangerous bacteria may be with other bacteria.
Developmental biologist Anna-Katerina (Kat) Hadjantonakis
Science Byte
It Takes Two: A Pair of Proteins Coordinate to Direct Development of Embryonic Cells

MSK researchers shed light on the signals that determine the fate of embryonic cells.
MSK medical oncologist Luis Diaz, Jr.
In the Clinic
The Science Behind the FDA’s Approval of an Immunotherapy for Mismatch Repair–Deficient Cancers

A new paper from MSK physician-scientist Luis Diaz presents the evidence on which the FDA approved the immunotherapy drug pembrolizumab for cancers with a specific genetic abnormality.
Lymph nodes and lymphatic vessels with adjacent blood vessels
Finding
Definitive Study Shows That People with Melanoma Do Not Need Immediate Lymph Node Removal

The results of a large, international randomized trial herald a change in medical practice for the treatment of melanoma.
American Society of Clinical Oncology logo
In the News
#ASCO17: Post-Conference Roundup of Themes and Trends

Read up on the progress being made in several key areas of cancer research, including immunotherapy, targeted therapy, precision surgery, and epigenetics.
Head shot of doctor with glasses, white shirt, and blue tie in his lab.
In the Clinic
Drug Reduces Recurrence Risk in Subset of Women with Breast Cancer

A drug was shown to improve outcomes in women with HER2-positive early breast cancer when added to standard therapy.
Ethan Basch
In the Clinic
Online Symptom-Monitoring Tool Improves Survival for Those Undergoing Chemotherapy for Metastatic Cancer

A study presented at the 2017 annual meeting of the American Society of Clinical Oncology showed that an online tool to monitor patients’ symptoms improved overall survival.
Medical oncologist Mark Robson
In the Clinic
Phase III Trial of Targeted Drug Shows Promise in Treating Metastatic Breast Cancer

Investigators found that olaparib extended progression-free survival by an average of three months in women with advanced breast cancer.
photo of sample blood vials
Finding
Could a Blood Test Detect Early-Stage Cancers?

A sensitive assay for detecting tumor DNA in the blood performed well in patients and may herald the development of a blood test for cancer screening.
Three syringes stuck into an orange and white bull’s-eye
In the Clinic
Drug Targeting Genetic Mutation Works across All Tumor Types

A drug effective in all cancer types with a mutation called a TRK fusion could be the first ever developed simultaneously in adults and children.